missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ CD23/Fc epsilon RII Antibody (lumiliximab) - Chimeric, Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28199-100ug
This item is not returnable.
View return policy
Description
CD23/Fc epsilon RII Monoclonal antibody specifically detects CD23/Fc epsilon RII in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| CD23/Fc epsilon RII | |
| Monoclonal | |
| Unconjugated | |
| P06734 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| lumiliximab | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| BLAST-2, CD23A, CD23CD23 antigen, CLEC4JC-type lectin domain family 4 member J, C-type lectin domain family 4, member J, Fc fragment of IgE, low affinity II, receptor for (CD23), FCE2Fc fragment of IgE, low affinity II, receptor for (CD23A), fc-epsilon-RII, IGEBF, Immunoglobulin E-binding factor, low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor | |
| FceR2/ CD23 | |
| 100 μg | |
| Adaptive Immunity, B Cell Development and Differentiation Markers, Biologically Active Proteins, Cancer, Immunology, Phospho Specific | |
| 2208 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction